Applied BioCode Corporation (TPE:6598)
Taiwan
· Delayed Price · Currency is TWD 23.60
-1.05 (-4.26%)
Mar 9, 2026, 1:30 PM CST
Applied BioCode Revenue
Applied BioCode had revenue of 122.82M TWD in the quarter ending September 30, 2025, with 63.87% growth. This brings the company's revenue in the last twelve months to 443.69M, up 14.85% year-over-year. In the year 2024, Applied BioCode had annual revenue of 343.07M, down -13.18%.
Revenue (ttm)
443.69M
Revenue Growth
+14.85%
P/S Ratio
5.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.43B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dynamic Medical Technologies | 1.43B |
| Wellell | 2.39B |
| A Plus Biotechnology | 825.52M |
| Diamond Biotechnology | 698.11M |
| OK Biotech | 1.64B |
| Medimaging Integrated Solution | 656.21M |
| WeLeader Biomedical | 1.11B |
| Taiwan Biomaterial | 203.27M |